Results 131 to 140 of about 306 (160)

A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease. [PDF]

J Crohns Colitis
Johnson AM, Askar M, Belani S, Khan A, Xu AA, Kassmeyer B, Said H, Santiago-Castro M, Devi J, Huang K, Jaiprada F, Seth N, Dulaney D, Loftus EV, Fenster M, Patel A, Bishu S, Ungaro RC, Shukla R, Yarur AJ, Deepak P.   +20 more
europepmc   +1 more source

Astatine-211 and actinium-225: two promising nuclides in targeted alpha therapy. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Zuo D, Wang H, Yu B, Li Q, Gan L, Chen W.   +5 more
europepmc   +1 more source

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons. [PDF]

Pulm Ther
Giulianelli G, Cocconcelli E, Fiorentù G, Bernardinello N, Balestro E, Spagnolo P.   +5 more
europepmc   +1 more source

Intestinal fibrosis associated with inflammatory bowel disease: Known and unknown. [PDF]

Chin Med J (Engl)
Zhang Y, Zhuang H, Chen K, Zhao Y, Wang D, Ran T, Zou D.   +6 more
europepmc   +1 more source

The CARD8 inflammasome dictates HIV/SIV pathogenesis and disease progression. [PDF]

Cell
Wang Q, Clark KM, Tiwari R, Raju N, Tharp GK, Rogers J, Harris RA, Raveendran M, Bosinger SE, Burdo TH, Silvestri G, Shan L.   +11 more
europepmc   +1 more source

AGMB-Jahrestagung in Köln 2011

netbib, 2011
openaire   +2 more sources

Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence. [PDF]

Front Oncol
Kumbhakar DV, Thakkar L, Akhand C, Sharaf S, Vemuganti GK.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

AGMB Tagung 2021

Bibliotheksdienst, 2021
exaly   +2 more sources

Jahrestagung 2022 der AGMB

Bibliotheksdienst, 2022
exaly   +2 more sources